MRVI
Price
$2.69
Change
-$0.02 (-0.74%)
Updated
Jul 25 closing price
Capitalization
387.29M
15 days until earnings call
ONWRF
Price
$4.60
Change
-$0.39 (-7.82%)
Updated
Jul 23 closing price
Capitalization
220.76M
Interact to see
Advertisement

MRVI vs ONWRF

Header iconMRVI vs ONWRF Comparison
Open Charts MRVI vs ONWRFBanner chart's image
Maravai LifeSciences Holdings
Price$2.69
Change-$0.02 (-0.74%)
Volume$886.56K
Capitalization387.29M
Onward Med
Price$4.60
Change-$0.39 (-7.82%)
Volume$3.93K
Capitalization220.76M
MRVI vs ONWRF Comparison Chart in %
Loading...
MRVI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ONWRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MRVI vs. ONWRF commentary
Jul 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MRVI is a Hold and ONWRF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 28, 2025
Stock price -- (MRVI: $2.69 vs. ONWRF: $4.60)
Brand notoriety: MRVI and ONWRF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MRVI: 51% vs. ONWRF: 433%
Market capitalization -- MRVI: $387.29M vs. ONWRF: $220.76M
MRVI [@Biotechnology] is valued at $387.29M. ONWRF’s [@Biotechnology] market capitalization is $220.76M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MRVI’s FA Score shows that 1 FA rating(s) are green whileONWRF’s FA Score has 0 green FA rating(s).

  • MRVI’s FA Score: 1 green, 4 red.
  • ONWRF’s FA Score: 0 green, 5 red.
According to our system of comparison, MRVI is a better buy in the long-term than ONWRF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MRVI’s TA Score shows that 4 TA indicator(s) are bullish while ONWRF’s TA Score has 5 bullish TA indicator(s).

  • MRVI’s TA Score: 4 bullish, 5 bearish.
  • ONWRF’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ONWRF is a better buy in the short-term than MRVI.

Price Growth

MRVI (@Biotechnology) experienced а +10.70% price change this week, while ONWRF (@Biotechnology) price change was -6.12% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.60%. For the same industry, the average monthly price growth was +17.32%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

MRVI is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+7.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MRVI($387M) has a higher market cap than ONWRF($221M). ONWRF YTD gains are higher at: -23.333 vs. MRVI (-50.642).
MRVIONWRFMRVI / ONWRF
Capitalization387M221M175%
EBITDA-190.13MN/A-
Gain YTD-50.642-23.333217%
P/E RatioN/AN/A-
Revenue242MN/A-
Total Cash285MN/A-
Total Debt371MN/A-
TECHNICAL ANALYSIS
Technical Analysis
MRVIONWRF
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
33%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
55%
Momentum
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
47%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
46%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 3 days ago
45%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
42%
Advances
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 6 days ago
50%
Declines
ODDS (%)
Bearish Trend 7 days ago
85%
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
20%
Aroon
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 6 days ago
41%
View a ticker or compare two or three
Interact to see
Advertisement
MRVI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ONWRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VFMFX43.280.25
+0.58%
Vanguard US Multifactor Admiral™
MRGRX59.110.28
+0.48%
MFS Core Equity I
MCCPX21.250.01
+0.05%
BlackRock Balanced Investor C
FERRX11.93-0.01
-0.08%
First Eagle Global Real Assets R6
FNARX47.85-0.22
-0.46%
Fidelity Natural Resources Fund

MRVI and

Correlation & Price change

A.I.dvisor indicates that over the last year, MRVI has been loosely correlated with CRDF. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if MRVI jumps, then CRDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRVI
1D Price
Change %
MRVI100%
-0.74%
CRDF - MRVI
40%
Loosely correlated
-4.11%
TECH - MRVI
39%
Loosely correlated
+0.53%
IGMS - MRVI
31%
Poorly correlated
-0.78%
MRNA - MRVI
31%
Poorly correlated
+0.41%
NRIX - MRVI
30%
Poorly correlated
-0.09%
More

ONWRF and

Correlation & Price change

A.I.dvisor tells us that ONWRF and MRVI have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ONWRF and MRVI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ONWRF
1D Price
Change %
ONWRF100%
N/A
MRVI - ONWRF
30%
Poorly correlated
-0.74%
VIR - ONWRF
30%
Poorly correlated
-1.91%
AGIO - ONWRF
23%
Poorly correlated
+0.88%
ACUT - ONWRF
9%
Poorly correlated
+6.80%
HLVX - ONWRF
3%
Poorly correlated
+0.47%
More